Enzyme replacement therapy can make a big difference to cancer patients, as Mary-Claire Mason reports
Most patients with pancreatic cancer are deficient in the enzymes they need to digest food, leaving them at risk of becoming malnourished. Research by Lynne McCallum has highlighted the importance of early pancreatic enzyme replacement therapy.
Nursing Standard. 29, 35, 21-21. doi: 10.7748/ns.29.35.21.s22
or
Alternatively, you can purchase access to this article for the next seven days. Buy now
Are you a student? Our student subscription has content especially for you.
Find out more